GlycA Inflammation Testing Market Expands with Rising Demand for Advanced Cardiometabolic Risk Diagnostics

https://researchintelo.com/rep....ort/glyca-inflammati

The GlycA Inflammation Testing Market is gaining strong momentum as healthcare systems increasingly adopt advanced biomarker-based diagnostics for early detection of chronic diseases. GlycA is an emerging inflammatory biomarker measured through nuclear magnetic resonance (NMR) spectroscopy, offering a more stable and comprehensive assessment of systemic inflammation compared to traditional markers.

 

researchintelo.com

GlycA Inflammation Testing Market Research Report 2033

According to our latest research, the Global GlycA Inflammation Testing market size was valued at $245 million in 2024 and is projected to reach $1.02 billion by 2033, expanding at a CAGR of 17.2% during 2024–2033.